Randomized Controlled Study Comparing the Efficacy and Tolerance of Bepotastine, a New 2nd Generation Antihistamine, to Fexofenadine, in Symptomatic Relief of Patients With Pruritic Cutaneous Disorders

Journal of Clinical & Experimental Dermatology Research
doi 10.4172/2155-9554.1000466
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group


Related search